Trial
NCT03233828
Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Carman Giacomantonio
Collaborators
Nova Scotia Health Authority
Condition
Melanoma (Skin)
Intervention
Aldesleukin
Why stopped
Low enrollment numbers.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-24